Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis

Abstract

To further explore the link between Chlamydia pneumoniae and multiple sclerosis (MS), we examined cerebrospinal fluid (CSF) samples from 71 patients with MS and from 72 patients suffering from other inflammatory neurological disorders (OIND) or noninflammatory neurological disorders (NIND). All samples were analysed by a touchdown nested polymerase chain reaction (n-PCR) forC. pneumoniae with primer sets which amplify target sequence genes encoding the major outer membrane protein (MOMP), the16S rRNA and the Hsp- 70 protein. A molecular study was also performed to evaluate genetic diversity among isolates of C. pneumoniae and to compare chlamydial sequences. PCR was found positive in 36.6% of total MS, in 28.1% of OIND and in 37.5% of NIND patients, without any statistical differences among the various groups examined. CSF PCR evidence of C. pneumoniae was significantly more frequent in relapsing-remitting (RR) than in secondary progressive (SP) (PB-0.001) and in primary progressive (PP)MS (PB-0.05), in clinically active than in clinically stable MS (PB-0.05) and in MRI active than in MRI inactive MS(PB-0.001). The analysis of CSF expression of each single C. pneumoniae-specific gene revealed that detectable levels of MOMP were significantly more frequent in MS patients with relapse (PB-0.05), whereas PCR positivity for MOMP and 16S rRNA genes were more represented in MS patients with clinical and MRI evidence of disease activity (PB-0.05). Similar rates for MOMP and 16S rRNA genes were detected in CSF of both MS patients and controls, whereas CSF PCR positivity for Hsp-70 gene was observed in only three active RR MS patients. Sequence analysis revealed significant homologies withC. pneumoniae compared to otherChlamydial spp. These findings confirm that theC. pneumoniae detection within the central nervous system (CNS) is not selectively restricted to MS, but accounts in a variety of neurological diseases. In addition, our results suggest that CSF C. pneumoniae-specific DNA detection can occur in a subset of MS patients with clinical and MRI active RR form in whom a C. pneumoniae brain chronic persistent infection may play a significant role in the development of disease.

Keywords

cerebrospinal fluid Chlamydia pneumoniae magnetic resonance imaging multiple sclerosis polymerase chain reaction

References

Noseworthy JH , Lucchinetti C , Rodriguez M , Weinshenker BG. Multiple sclerosis . N Engl J Med 2000; 343: 938-952 .

Lublin DF , Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey . Neurology 1996; 46: 907-911 .

Meinl E. Concepts of viral pathogenesis of multiple sclerosis . Curr Opin Neurol 1999; 12: 303-307 .

Hemmer B , Cepok S , Nessler S , Sommer N. Pathogenesis of multiple sclerosis: an update on immunology . Curr Opin Neurol 2002; 15: 227-231 .

Perron H , Garson JA , Bedin F , Beseme F , Paranhos-Baccala G , Komurian-Pradel F. Molecular identification of a novel retro-virus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis . Proc Natl Acad Sci USA 1997; 94: 7583-7588 .

Wandinger K , Jabs W , Siekhaus A , Bubel S , Trillenberg P , Wagner H. Association between clinical disease activity and Epstein-Barr virus reactivation in MS . Neurology 2000; 55: 178-184 .

Soldan SS , Berti R , Salem N , Secchiero P , Flamand L , Calabresi PA et al. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA . Nat Med 1997; 3: 1394-1397 .

Yucesan C , Sriram S. Chlamydia pneumoniae infection of the central nervous system . Curr Opin Neurol 2001; 14: 355-359 .

Permutter LJ , Darvish M. Possible relationship of Chlamydia to multiple sclerosis . Med Hypoth 1983; 12: 95-98 .

10.

Sriram S , Stratton CW , Yao S , Tharp A , Ding L , Bannan JD et al. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis . Ann Neurol 1999; 46: 6-14 .

11.

Boman J , Roblin PM , Sundstrom P , Sandstrom M , Hammers-chlag MR. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS . Neurology 2000; 54: 265-265 .

12.

Treib J , Haass A , Stille W , Maass M , Stephan C , Holzer G et al. Multiple sclerosis and Chlamydia pneumoniae . Ann Neurol 2000; 47: 408-408 .

13.

Morre SA , De Groot CJ , Killestein J , Meijer CJ , Polman CH , Van der Valk P et al.

Is Chlamydia pneumoniae present in the central nervous system of multiple sclerosis patients?

Ann Neurol 2000; 48: 399-399 .

14.

Pucci E , Taus C , Cartechini E , Morelli M , Giuliani G , Clementi M et al. Lack of Chlamydia infection of the central nervous system in multiple sclerosis . Ann Neurol 2000; 48: 339-400 .

15.

Hammerschlag MR , Ke Z , Lu F , Roblin P , Boman J , Kalman B.

Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis?

J Clin Microbiol 2000; 38: 4274-4276 .

16.

Layh-Schmitt G , Bendl C , Hildt U , Dong-Si T , Juttler E , Schnitzler P et al. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis . Ann Neurol 2000; 47: 652-655 .

17.

Gieffers J , Pohl D , Treib J , Dittmann R , Stephan C , Klotz K et al. Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis . Ann Neurol 2001; 49: 585-589 .

18.

Derfuss T , Gurkov R , Then Bergh F , Goebels N , Hartmann M , Barz C et al. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response . Brain 2001; 124: 1325-1335 .

19.

Saiz A , Marcos MA , Graus F , Vidal J , Jimenez de Anta MT. No evidence of CNS infection with Chlamydia pneumoniae in patients with multiple sclerosis . J Neurol 2001; 248: 617-618 .

20.

Sotgiu S , Piana A , Pugliatti M , Sotgiu A , Deiana GA , Sgaramella E et al. Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls . Mult Scler 2001; 7: 371-374 .

21.

Sotgiu S , Piana A , Pugliatti M , Sotgiu A , Deiana GA , Sgaramella E et al. PCR-based method for isolation and detection of Chlamydia pneumoniae DNA in cerebrospinal fluid . Clin Diagn Lab Immunol 2001; 8: 499-502 .

22.

Hao Q , Miyashita N , Matsui M , Wang HY , Matsushima T , Saida T. Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis . Mult Scler 2002; 8: 436-440 .

23.

Kaufman M , Gaydos CA , Sriram S , Boman J , Tondella ML , Norton HJ. Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results . Mult Scler 2002; 8: 289-294 .

24.

Poser CM , Paty DW , Scheinberg L , McDonald WI , Davis FA , Ebers GC et al. New diagnostic criteria for MS: guidelines for research protocols . Ann Neurol 1983; 13: 227-231 .

25.

Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability scale (EDSS) . Neurology 1983; 33: 1444-1452 .

26.

Kwok S , Higushi R. Avoiding false positives with PCR . Nature 1989; 339: 237-238 .

27.

Sambrook J , Fritsch EF , Maniatis T. Molecular cloning: a laboratory manual, second edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press , 1989: E-3-E-14.

28.

Cultrera R , Seraceni S , Contini C. Efficacy of a novel reverse transcriptase-polymerase chain reaction (RT-PCR) for detecting Toxoplasma gondii bradyzoite gene expression in human clinical specimens . Mol Cell Probes 2002; 16: 31-39 .

29.

Cunningham AF , Johnston SL , Julious SA , Lampe FC , Ward ME. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children . Eur Resp J 1998; 11: 345-349 .

30.

Don RH , Cox PT , Wainwright BJ , Baker K , Mattick JS. Touch-down PCR to circumvent spurious priming during gene amplification . Nucleic Acid Res 1991; 19: 4008-4008 .

31.

Mahony JB , Chong S , Coombes BK , Smieja M , Petrich A. Analytical sensitivity, reproducibility of results and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells . J Clin Microbiol 2000; 38: 2622-2627 .

32.

Valassina M , Migliorini L , Sansoni A , Sani G , Corsaro D , Cusi MG et al. Search for Chlamydia pneumoniae genes and their expression in atherosclerotic plaques of carotid arteries . J Med Microbiol 2001; 50: 228-232 .

33.

Gröndahl B , Puppe W , Hoppe A , Kü hne I , Weigl JAI , Schmitt HJ. Rapid identification of nine microrganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility study . J Clin Microbiol 1999; 37: 1-7 .

34.

Contini C , Cultrera R , Seraceni S , Segala D , Romani R , Fainardi E et al. The role of stage specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in AIDS patients . J Med Microbiol 2002; 51: 879-890 .

35.

Karlin S , Altschul SF. Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes . Proc Natl Acad Sci USA 1990; 87: 2264-2268 .

36.

Numazaki K , Chibar S. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS . Neurology 2001; 57: 746-746 .

37.

Contini C , Fainardi E , Seraceni S , Granieri E , Castellazzi M , Cultrera R. Molecular identification and antibody testing of Chlamydophila pneumoniae in a subgroup of patients with HIV-Associated Dementia Complex. Preliminary results . J Neuroimmunol 2003; 136: 172-177 .

38.

Bruck W , Porada P , Poser S , Rieckmann P , Hanefeld F , Kretzschmar HA et al. Monocyte/macrophage differentiation in early multiple sclerosis lesions . Ann Neurol 1995; 38: 788-796 .

39.

Lidington EA , McCormack AM , Yacoub MH , Rose ML. The effects of monocytes on the transendothelial migration of T lymphocytes . Immunology 1998; 94: 221-227 .

40.

Kermode AG , Tofts PS , Thompson AJ , MacManus DG , Rudge P , Kendall BE et al. Heterogeneity of blood brain barrier changes in multiple sclerosis: an MRI study . Neurology 1990; 40: 229-235 .

41.

Stratton CW , Mitchell WM. The immunopathology of Chlamydial lesions . Antimicr Infect Dis Newslett 1997; 16: 89-94 .

42.

Quinn TC.

Chlamydia pneumoniae and multiple sclerosis: innocent bystander or culprit?

Ann Neurol 2001; 49: 556-558 .